Suppr超能文献

Cautious interpretation of antiphospholipid antibodies in COVID-19.

作者信息

Mehta Sudhir, Bhandari Sudhir, Mehta Shaurya

机构信息

Depatment of Medicine, SMS Medical College (University Medical School), Jaipur, India.

Depatment of Medicine, SMS Medical College (University Medical School), Jaipur, India.

出版信息

Clin Chim Acta. 2020 Oct;509:166. doi: 10.1016/j.cca.2020.06.024. Epub 2020 Jun 15.

Abstract
摘要

相似文献

1
Cautious interpretation of antiphospholipid antibodies in COVID-19.
Clin Chim Acta. 2020 Oct;509:166. doi: 10.1016/j.cca.2020.06.024. Epub 2020 Jun 15.
2
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
Thromb Res. 2020 Nov;195:74-76. doi: 10.1016/j.thromres.2020.07.016. Epub 2020 Jul 8.
3
Researchers Home in on COVID-19 Severity Biomarkers.
JAMA. 2020 Jul 14;324(2):128. doi: 10.1001/jama.2020.11397.
4
Interleukin-6 as a potential biomarker of COVID-19 progression.
Med Mal Infect. 2020 Jun;50(4):382-383. doi: 10.1016/j.medmal.2020.04.002. Epub 2020 Apr 4.
5
Emerging key laboratory tests for patients with COVID-19.
Clin Biochem. 2020 Jul;81:13-14. doi: 10.1016/j.clinbiochem.2020.04.009. Epub 2020 Apr 30.
6
SARS-CoV-2-related atypical thyroiditis.
Lancet Diabetes Endocrinol. 2020 Sep;8(9):739-741. doi: 10.1016/S2213-8587(20)30266-7. Epub 2020 Jul 30.
7
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
Allergy Asthma Proc. 2020 Nov 1;41(6):e80-e82. doi: 10.2500/aap.2020.41.200079.
8
Two consecutive myocardial tissue insults for inpatients with COVID-19.
Crit Care. 2020 May 26;24(1):259. doi: 10.1186/s13054-020-02981-9.
9
Covid-19 antibody tests: a briefing.
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
10
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
J Thromb Thrombolysis. 2020 Oct;50(3):580-586. doi: 10.1007/s11239-020-02182-9.

引用本文的文献

1
NETosis and SARS-COV-2 infection related thrombosis: a narrative review.
Thromb J. 2022 Mar 30;20(1):13. doi: 10.1186/s12959-022-00375-1.
2
COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?
Clin Med Insights Arthritis Musculoskelet Disord. 2020 Dec 3;13:1179544120978667. doi: 10.1177/1179544120978667. eCollection 2020.
3
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.
SN Compr Clin Med. 2020;2(11):2048-2058. doi: 10.1007/s42399-020-00521-8. Epub 2020 Sep 19.
4
Brain autopsies in fatal COVID-19 and postulated pathophysiology: more puzzling than a Rubik's cube.
J Clin Pathol. 2021 Sep;74(9):612-613. doi: 10.1136/jclinpath-2020-206967. Epub 2020 Sep 9.
5
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Clin Rheumatol. 2020 Sep;39(9):2529-2543. doi: 10.1007/s10067-020-05275-1. Epub 2020 Jul 11.

本文引用的文献

1
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
2
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
3
Lupus anticoagulant is frequent in patients with Covid-19.
J Thromb Haemost. 2020 Aug;18(8):2064-2065. doi: 10.1111/jth.14867. Epub 2020 May 11.
4
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
5
Lupus Anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?
Thromb Res. 2010 Jan;125(1):102-4. doi: 10.1016/j.thromres.2009.09.001. Epub 2009 Sep 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验